Beyond the Off-Label: A Systematic Review of What We Know About Clozapine Use for Children

被引:2
|
作者
Pimenta de Figueiredo, Thales [1 ]
de Almeida, Igor Ribeiro [1 ]
de Freitas, Filipe Augusto Cursino [2 ]
Kubrusly, Caio Hage Chahine [1 ]
Alvim-Soares Jr, Antonio Marcos [1 ]
de Miranda, Debora Marques [1 ]
机构
[1] Univ Fed Minas Gerais, 190 Ave Prof Alfredo Balena, BR-30130100 Belo Horizonte, MG, Brazil
[2] Fundacao Hosp Estado Minas Gerais, Belo Horizonte, Brazil
关键词
clozapine; children; psychopharmacology; aggressive behavior; DOUBLE-BLIND; ADOLESCENTS; ANTIPSYCHOTICS; AGGRESSION; DISORDER; YOUTHS;
D O I
10.1089/cap.2024.0070
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: It is essential not to delay behavior management and control for aggression, violence, and impulsive behavior in young people. Clozapine has been widely used in adolescents and adults to manage violence and aggression in Schizophrenia. However, there are limited data on the use of clozapine in children, and no systematic review has addressed its use in this population.Objective and Methods: To better understand the conditions under which clozapine is used as a therapeutic alternative for nonschizophrenic diagnoses and to assess the current evidence supporting its prescription to children, a systematic review was conducted. The review followed PRISMA guidelines and was registered in PROSPERO under the ID CRD42024537707.Results: The review identified that all the studies used clozapine to address externalizing behavior, particularly aggressive behavior, and found positive outcomes supporting its use for treating children with treatment-resistant aggression. The studies also found that clozapine was well-tolerated in all cases. However, the studies were limited and mainly consisted of open trials without a control group.Conclusion: Further high-quality research is needed to establish precise guidelines for using clozapine in children.
引用
收藏
页码:e419 / e426
页数:8
相关论文
共 50 条
  • [1] Off-Label Use of Clozapine in Children and Adolescents-A Literature Review
    Rachamallu, Vivekananda
    Elberson, Benjamin W.
    Vutam, Emily
    Aligeti, Manish
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E406 - E416
  • [2] What do Swiss community pharmacists know about off-label use?
    Berger, J.
    Varini, S.
    Di Giovanni, S.
    Bugnon, O.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 168 - 168
  • [3] CLOZAPINE - WHAT WE KNOW ABOUT IT
    ORTEGASOTO, HA
    BRUNNER, E
    SALUD MENTAL, 1993, 16 (04) : 14 - 25
  • [4] Off-label Use of Azathioprine in Dermatology A Systematic Review
    Schram, Mandy E.
    Borgonjen, Rinke J.
    Bik, Cathelijne M. J. M.
    van der Schroeff, Jan G.
    van Everdingen, Jannes J. E.
    Spuls, Phyllis I.
    ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 474 - 488
  • [5] Off-label use of ceftaroline fosamil: A systematic review
    Pani, Arianna
    Colombo, Fabrizio
    Agnelli, Francesca
    Frantellizzi, Viviana
    Baratta, Francesco
    Pastori, Daniele
    Scaglione, Francesco
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (05) : 562 - 571
  • [6] Off-Label Use of Spesolimab in Dermatology: A Systematic Review
    Sood, Siddhartha
    Waked, Jihad
    Merchant, Nabil
    Abduelmula, Abrahim
    Mufti, Asfandyar
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
  • [7] A literature review on off-label drug use in children
    Chiara Pandolfini
    Maurizio Bonati
    European Journal of Pediatrics, 2005, 164 : 552 - 558
  • [8] A literature review on off-label drug use in children
    Pandolfini, C
    Bonati, M
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (09) : 552 - 558
  • [9] Off-label drug use in oncology: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 251 - 258
  • [10] OFF-LABEL USE OF MEDICINES IN CHILDREN
    Mir, Aamir Nabi
    Geer, Mohammad Ishaq
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (05): : 1820 - 1828